VIDA
LIVE

Serial Number

98717456

Owner

Vivaldi Therapeutics, Inc.

Attorney

Kristen Ruisi

Filing Date

Aug 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VIDA Trademark

Serial Number: 98717456

VIDA is a trademark filed by Vivaldi Therapeutics, Inc. on August 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

Vivaldi Therapeutics, Inc.

2929 Arch Street
Philadelphia, PA 19104

Entity Type: 03

Trademark Details

Filing Date

August 26, 2024

Registration Date

Not Registered

Goods & Services

Educational services, namely, providing educational resources and treatment planning in the field of cancer treatment

Downloadable software for cancer medication dose calculation and monitoring; Downloadable computer application software for mobile devices and computers, namely, software for therapeutic drug monitoring in the fields of cancer treatment, pharmacy, and patient statistics.

Pharmaceutical preparations for use in the treatment and prevention of cancer

Providing information in the field of cancer treatment; Medical services in the nature of cancer treatment planning; consultation services in the field of cancer treatment; providing a website featuring information about cancer treatment planning

Research and development of pharmaceuticals for the treatment of cancer; research and development in the field of cancer treatment plans; technological research in the field of cancer

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 11, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 11, 2025 GNSL
SUSPENSION LETTER WRITTEN
Aug 11, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
NEW APPLICATION ENTERED
Aug 26, 2024 NWAP